Activity of gemcitabine and carboplatin in advanced non-small cell lung cancer: a phase II trial
- 7 December 2001
- journal article
- clinical trial
- Published by Elsevier in Lung Cancer
- Vol. 36 (1) , 99-103
- https://doi.org/10.1016/s0169-5002(01)00452-4
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2000
- Phase I-II Study of Gemcitabine and Carboplatin in Stage IIIB-IV Non–Small-Cell Lung CancerJournal of Clinical Oncology, 1999
- Gemcitabine in locally advanced and metastatic non-small cell lung cancer: the Central European phase II studyLung Cancer, 1998
- Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)Lung Cancer, 1998
- Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II studyEuropean Journal Of Cancer, 1996
- Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.Journal of Clinical Oncology, 1994
- Toward the Primary Prevention of CancerScience, 1991
- Cisplatin Dose Intensity in Non-Small Cell Lung Cancer: Phase II Results of a Day 1 and Day 8 High-Dose RegimenJNCI Journal of the National Cancer Institute, 1989
- A Comparison of the Toxicity and Efficacy of Cisplatin and Carboplatin in Advanced Ovarian CancerActa Oncologica, 1989
- A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma.Journal of Clinical Oncology, 1986